The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Development of a disease-specific measure of quality of life in myelodysplastic syndromes (MDS): The “QUALMS-1”.
Gregory Alan Abel
No relevant relationships to disclose
Stephanie Lee
No relevant relationships to disclose
Richard M. Stone
No relevant relationships to disclose
David P. Steensma
No relevant relationships to disclose
Nancy Young
No relevant relationships to disclose
Alice Houk
No relevant relationships to disclose
B Taylor Hastings
No relevant relationships to disclose
Yolanda Martins
No relevant relationships to disclose
Robert Klaassen
No relevant relationships to disclose